Biotechnology Industry | Healthcare Sector | Mr. Michael Alexander Iverson CEO | OTC PINK Exchange | CA63010P2098 ISIN |
Canada Country | - Employees | - Last Dividend | 7 Jul 2021 Last Split | - IPO Date |
NanoSphere Health Sciences Inc. is a pioneering nano-biotechnology company that has its main operations in the United States and Canada. Established in 2005, the company has dedicated itself to the innovative use of nanotechnology in the delivery of biologically active compounds. With its headquarters in Vancouver, Canada, NanoSphere Health Sciences Inc. aims to revolutionize the bioavailability of supplements, nutraceuticals, and over-the-counter medications. Its core focus spans across various industries including cannabis, pharmaceutical, and animal health, where it seeks to improve efficacy and outcomes through its cutting-edge NanoSphere Delivery System.
This platform represents the cornerstone of NanoSphere Health Sciences Inc.'s offering. Utilizing advanced nanotechnology, the NanoSphere Delivery System enhances the bioavailability and effectiveness of various compounds. By encapsulating the active ingredients in nano-sized carriers, this system ensures a more efficient delivery and absorption into the body. This technology has wide applications in the delivery of supplements, nutraceuticals, and over-the-counter medications, addressing the needs of the cannabis, pharmaceutical, and animal health industries.